Healthcare Services Group, Inc. (HCSG) fair value analysis
Nasdaq · Updated 2026-10-19
HCSG price how computed
Forward Fair Value verdict
Fairly valuedHCSG is trading at within about 10% of estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $21.13
- Sector
- Healthcare
- 12-month range
- $17.02–$25.31
- Market cap
- $1.45B
- From 52-week high
- -16.5%
- Shares outstanding
- 68.6M
- Rank in Healthcare by discount to fair value
- #50 of 108
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
Healthcare Services Group, Inc. is a provider of housekeeping, laundry, and dietary services to senior living communities, hospitals, and other healthcare facilities. The company operates throughout the United States.
HCSG currently ranks #50 of 108 Healthcare stocks by discount to fair value. It has screened as Fairly valued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $1.45B
- P/E (trailing)
- 12x
- Revenue (TTM)
- $1.86B
- Net margin
- 6.6%
- EPS (TTM)
- $1.72
- Gross margin
- 15.9%
- Debt / equity
- 0.03
- Revenue growth (3-yr avg)
- 4.8%
- Shares outstanding
- 68.6M
Derived indicators how computed
- Quality grade
- C
- Margin trend
- Expanding
- 52-week position
- The lower-middle quarter of its range
- DCF cross-check
- Fairly Valued
Technicals how computed
- RSI (14-day)
- 48 · neutral
- 50-day average
- $21.59
- 200-day average
- $21.16
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Dividends how computed
- Dividend
- None in the last 12 months (last ex-date 2022-11-17)
Earnings how computed
- Last 8 quarters vs consensus
- 5 beat, 3 missed
- Quarter by quarter
- 2026-06 ▲ beat (+60.0%)
2026-03 ▲ beat (+68.2%)
2025-12 ▲ beat (+96.2%)
2025-09 ▲ beat (+195.0%)
2025-06 ▼ miss (-320.0%)
2025-03 ▲ beat (+21.1%)
2024-12 ▼ miss (-18.3%)
2024-09 ▼ miss (-5.0%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 4 buy · 3 hold · 0 sell (7 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $26.7
- Target vs last price
- +26.4%
What our data shows for HCSG
- Our model validated 17 trailing price-to-earnings windows for HCSG, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $17.02–$25.31.
- The 14-day relative strength index sits at a neutral 48.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for HCSG
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent HCSG news
TickrTrends' derived news-sentiment signal for HCSG is currently mixed, computed from recent coverage.
- Q3 2026 Healthcare Services Group, Inc. Earnings Call Transcript (gurufocus.com, 2026-10-21)
TickrTrends take: Healthcare Services Group operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends metrics. The company's Q3 2026 earnings call provides an opportunity to evaluate whether operational performance and guidance support the fair value assessment or suggest a shift in valuation standing. Investors monitoring the fairly valued designation should pay attention to trends in revenue, margins, and forward guidance during this period to determine if the current valuation pricing remains appropriate. - Healthcare Services Group, Inc. (HCSG) Q3 2026 Earnings Call Transcript (seekingalpha.com, 2026-10-21)
TickrTrends take: Healthcare Services Group operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends metrics. With the company hosting its Q3 2026 earnings call, investors monitoring valuation should focus on whether management commentary reveals changes in operational efficiency, margins, or growth trajectory that could support or challenge the current fair value assessment. Any material shifts in the company's financial performance or forward guidance could influence whether the fairly valued designation remains appropriate. - Is Healthcare Services Group Inc (HCSG) Stock Overvalued After Q3 Earnings Beat? EPS at $0.36 vs Estimate of $0.24; GF Score 76/100 (gurufocus.com, 2026-10-21)
TickrTrends take: Healthcare Services Group Inc reported third quarter earnings per share that exceeded analyst expectations, delivering 36 cents against a consensus estimate of 24 cents. TickrTrends currently assesses HCSG as fairly valued despite this earnings outperformance, suggesting the market has already incorporated the positive results into the stock price. For valuation-focused investors, the key question becomes whether the company can sustain this level of earnings performance going forward, as a fairly valued assessment implies limited margin of safety at current levels.
More HCSG news
- Verda Healthcare Partners with Astrana Health (ASTH) to Expand Culturally Sensitive Care in Houston and Phoenix (gurufocus.com, 2026-10-12)
- POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination (manilatimes.net, 2026-10-09)
- Healthcare Services Group: Adding To A Non-Convincing Story (NASDAQ:HCSG) (seekingalpha.com, 2026-10-09)
What people are saying
Follow the HCSG conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — HCSG's quality grade improved from D to C this week, while its RSI indicator moved out of oversold territory into neutral range. These shifts in TickrTrends' derived indicators suggest modest positive momentum in the healthcare sector stock, which maintains a fairly valued status according to current assessments.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — TickrTrends' derived indicators show that HCSG moved up in sector discount ranking this week, improving from position 69 to position 63 among Healthcare sector stocks. The company maintains a Fairly valued verdict on its current valuation. This upward movement in ranking suggests the stock has become relatively more attractively priced within its sector peer group.
- 2026-09-21 — Healthcare Services Group Inc (HCSG) moved into oversold territory this week according to relative strength index readings, shifting from a neutral zone. The stock's current valuation assessment remains fairly valued based on TickrTrends' derived indicators.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is HCSG stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), HCSG is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is HCSG's TickrTrends verdict?
HCSG's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does HCSG compare to other Healthcare stocks?
HCSG ranks #50 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is HCSG overbought or oversold?
HCSG's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does HCSG pay a dividend?
HCSG has paid no dividend in the last twelve months; its last ex-dividend date on file was 2022-11-17.
Does HCSG usually beat earnings estimates?
Over its last 8 reported quarters HCSG beat the consensus estimate 5 times and missed 3 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about HCSG?
Of 7 analysts covering HCSG, 4 rate it a buy, 3 a hold and 0 a sell - buy-leaning, with a consensus price target of $26.7 (+26.4% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Healthcare
Head-to-head comparisons
HCSG vs EXEL · HCSG vs HSIC · HCSG vs IQV · HCSG vs KNSA · HCSG vs LIVN